C12Y 301/03009
Glucose-6-phosphatase
Official title: Glucose-6-phosphatase (3.1.3.9)
C12Y301/03009 (Glucose-6-phosphatase) appears on 15 US grants and 37 published applications in this corpus.
Search patents in C12Y- Granted patents
- 15
- Published applications
- 37
- Assignees
- 29
- Inventors
- 113
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 4 |
| 2020 | 0 | 5 |
| 2021 | 1 | 2 |
| 2022 | 2 | 5 |
| 2023 | 0 | 6 |
| 2024 | 4 | 3 |
| 2025 | 2 | 6 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Vectors encoding a glucose-6-phosphatase (G6PASE-A) for gene therapy1 Sep 2026US 12,723,263 B2Genethon
- Methods and compositions for treating glycogen storage diseases28 Jul 2026US 12,692,512 B2Ultragenyx Pharmaceutical Inc.
- Adeno-associated virus vectors encoding modified G6PC and uses thereof14 Oct 2025US 12,440,580 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods for detecting target analytes using synthetic biological circuits that modify glucose levels in a cell-free system4 Feb 2025US 12,215,370 B2The Governing Council of the University of Toronto
- Enzymatic preparation of glucosamine17 Sep 2024US 12,091,697 B2Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences
- Derivatives, immunogens, and antibodies and use of the same in detection of ecstasy-class compounds13 Aug 2026US 2026/0234121 A1Siemens Healthcare Diagnostics Inc.
- Compositions and methods for promoting liver regeneration by gene editing in metabolic liver disease11 Dec 2025US 2025/0376698 A1Duke University
- Compositions comprising a muscle active promoter and methods of using the same26 Jun 2025US 2025/0205367 A1Duke University
- Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage disease29 May 2025US 2025/0170070 A1ModernaTX, Inc.
- Antisense oligonucleotide and composition for prevention or treatment of glycogen storage disease type ia27 Mar 2025US 2025/0101431 A1Daiichi Sankyo Company, Limited
Most cited
By later US patents
- Genetic switches for butanol production10US 9,181,566 B2Butamax Advanced Biofuels LLC · 2015
- Materials and methods for treatment of glycogen storage disease type 1A4US 11,866,727 B2Crispr Therapeutics AG · 2024
- Adeno-associated virus vectors for treatment of glycogen storage disease4US 9,644,216 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2017
- Adeno-associated virus vectors encoding modified G6PC and uses thereof1US 10,415,044 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2019